The Centre for Cellular and Molecular Platforms (C-CAMP), Bengaluru, India’s premier bio-incubator and innovation hub, has signed a Letter of Intent with the Roslin Innovation Centre, at the University of Edinburgh, under the Indo UK Sister Innovation Hub agreement.

The aim of the LOI is to foster and promote the best deep science innovations that impact both science and society in India and UK.

The LOI was signed by Dr. Taslimarif Saiyed, CEO and Director of C-CAMP and John Mackenzie, CEO of the Roslin Innovation centre. This partnership with Roslin, whose scientists created the world’s first cloned mammal, Dolly the sheep, will help develop joint translational research in livestock genomics and health. It will also open up avenues to C-CAMP and Roslin’s network of partners to develop new, productive relationships for doing business in both India and the UK.

The LoI which was signed in presence of Dr. Renu Swarup, Secretary, Department of Biotechnology, India marks the inking of the Second Sister Innovation Hub by CCAMP after CCAMP’s first with California Institute for Quantitative Biosciences, QB3 in 2016.  The collaboration with the Roslin Innovation Centre will strengthen Indo-UK bilateral ties in science-based entrepreneurship, research and business, especially in the Agriculture and Animal Health sectors. The new signing is envisioned to also augment C-CAMP’s current efforts in Agritech and Allied space under its recently launched Agri Innovation Centre program.

On the occasion of the signing Dr. Taslimarif Saiyed, CEO & Director, C-CAMP said “This is only a beginning to wonderful discussions with colleagues at Roslin  Institute, the origin of Dolly The Sheep. Looking forward to possible collaborations on agritech, animal health and to build more bilateral innovation ties leveraging science for societal impact.”

John Mackenzie, CEO of the Roslin Innovation centre, at the University of Edinburgh said: “We are delighted to have signed this agreement with CCAMP, which will help champion a range of important animal health projects in both countries. In addition, we hope to encourage others to follow our lead and help develop truly transformational technologies in livestock genomics and health.”